This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

BT And Accelrys Help Scientists Gain Valuable Medical Insights From Big Data

SAN DIEGO, May 30, 2013 /PRNewswire/ -- BT and Accelrys, Inc. today announced that the two companies are working closely together to help garner valuable medical insights from vast public health datasets, using BT for Life Sciences cloud compute solutions combined with Accelrys Enterprise Platform and Accelrys Pipeline Pilot.


The United Kingdom (UK) state-funded National Health Service (NHS) has been in existence for more than 60 years. During that period, the UK population has generated a wealth of health data and much of this information is computerized. In addition, a vast amount of information on the operational delivery of health care has been made available under the UK open data policy.  Similar datasets are available in other countries, most notably from the Food and Drug Administration (FDA) in the United States.

BT has collated publically available health system and social care information into a research repository intended for use by the life sciences and health care industries as well as academia, initially hosted in the United States and UK, but available for global access. Such data can provide valuable insight into a number of healthcare topics, such as disease prevalence, impact of ethnic mix and adverse drug reactions. However, the information is often contained in very large datasets and may be unstructured in nature.

The combination of BT's Cloud Compute platform, the Accelrys Enterprise Platform and Pipeline Pilot has proved capable of finding buried value in massive amounts of data. BT and Accelrys are focused on supporting the Big Data challenges of their customers.   This initiative demonstrates the capabilities of their combined technology approaches as they focus through their collaboration on developing solutions to address the significant market need to unlock the value of large datasets.  The mutual goal is to let the scientist focus on science and not worry about the complexities of information management, particularly in a cloud environment.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,813.39 +1.20 0.01%
S&P 500 2,088.87 -0.27 -0.01%
NASDAQ 5,116.1430 +13.3350 0.26%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs